Abstract:Background Heterogeneity of endothelial cells (ECs) is a hallmark of the vascular system which may impact the development and management of vascular disorders. Despite the tremendous progress in differentiation of human embryonic stem cells (hESCs) towards endothelial lineage, differentiation into arterial and venous endothelial phenotypes remains elusive. Additionally, current differentiation strategies are hampered by inefficiency, lack of reproducibility, and use of animal-derived products. Methods To direct the differentiation of hESCs to endothelial subtypes, H1- and H9-hESCs were seeded on human plasma fibronectin and differentiated under chemically defined conditions by sequential modulation of glycogen synthase kinase-3 (GSK-3), basic fibroblast growth factor (bFGF), bone morphogenetic protein 4 (BMP4) and vascular endothelial growth factor (VEGF) signaling pathways for 5 days. Following the initial differentiation, the endothelial progenitor cells (CD34 + CD31 + cells) were sorted and terminally differentiated under serum-free conditions to arterial and venous ECs. The transcriptome and secretome profiles of the two distinct populations of hESC-derived arterial and venous ECs were characterized. Furthermore, the safety and functionality of these cells upon in vivo transplantation were characterized. Results Sequential modulation of hESCs with GSK-3 inhibitor, bFGF, BMP4 and VEGF resulted in stages reminiscent of primitive streak, early mesoderm/lateral plate mesoderm, and endothelial progenitors under feeder- and serum-free conditions. Furthermore, these endothelial progenitors demonstrated differentiation potential to almost pure populations of arterial and venous endothelial phenotypes under serum-free conditions. Specifically, the endothelial progenitors differentiated to venous ECs in the absence of VEGF, and to arterial phenotype under low concentrations of VEGF. Additionally, these hESC-derived arterial and venous ECs showed distinct molecular and functional profiles in vitro. Furthermore, these hESC-derived arterial and venous ECs were nontumorigenic and were functional in terms of forming perfused microvascular channels upon subcutaneous implantation in the mouse. Conclusions We report a simple, rapid, and efficient protocol for directed differentiation of hESCs into endothelial progenitor cells capable of differentiation to arterial and venous ECs under feeder-free and serum-free conditions. This could offer a human platform to study arterial–venous specification for various applications related to drug discovery, disease modeling and regenerative medicine in the future.

6 Differentiation of human embryonic stem cells towards the endothelial lineage involves microRNAs

Efficient Differentiation of Human Embryonic Stem Cells to Arterial and Venous Endothelial Cells under Feeder- and Serum-Free Conditions

Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells.

Microrna-200c And-150 Play An Important Role In Endothelial Cell Differentiation And Vasculogenesis By Targeting Transcription Repressor Zeb1

Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells

Differentiation of Human Embryonic Stem Cells to Endothelial Cells via Improved Three-dimension Approach

Induced differentiation of human embryonic stem cells into endothelial cells

Differentiation Of Embryonic Stem Cells To Vascular Cell Lineages

MiR‐218 Regulated Cardiomyocyte Differentiation and Migration in Mouse Embryonic Stem Cells by Targeting PDGFRα

DIFFERENTIATING INTO ENDOTHELIOID CELLS FROM MURINE EMBRYONIC STEM CELL

e0205 MicroRNA regulation of cardiomyocyte lineages from bone marrowderived mesenchymal stem cells

Signalling pathways that regulate endothelial differentiation from stem cells.

Primary Study of Human Embryonic Stem Cell on Differentiation of Vascular Endothelial Cells

Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture.

Microenviroment-dependent Endothelial Differentiation of Human Mesenchymal Stem Cells in vitro

PCR Array Profiling of miRNA Expression Involved in the Differentiation of Amniotic Fluid Stem Cells toward Endothelial and Smooth Muscle Progenitor Cells

Molecular Mechanisms Regulating the Differentiation of Embryonic Stem Cells into Endothelial Cells

Endothelial Lineage Differentiation from Induced Pluripotent Stem Cells is Regulated by MicroRNA-21 and Transforming Growth Factor Β2 (Tgf-Β2) Pathways

[Induced differentiation of mouse embryonic stem cell into endothelial cell in vitro]

MicroRNA-199a Induces Differentiation of Induced Pluripotent Stem Cells into Endothelial Cells by Targeting Sirtuin 1

Differentiation of the human marrow mesenchymal stem cells into vascular endothelium-like cells in vitro